Long Term Outcomes for Alemtuzumab Based Reduced Intensity Conditioning Transplant for Myelodysplastic Syndromes and Acute Myeloid Leukaemia
2012
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI